CoChat

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Treating retinal vein occlusions in France, Germany, and Italy: an analysis of treatment patterns, resource consumption, and costs

Augustin, Albert J., Sahel, Jose-Alain, Cerulli, Luciano, Texier-Richard, Brigitte, Buchholz, Patricia M., Kobelt, Gisela · 2012 · European Journal of Ophthalmology

Abstract

Purpose: To describe treatment patterns among patients with central or branch retinal vein occlusion (CRVO or BRVO) in France, Germany, and Italy, and to estimate retinal vein occlusion (RVO)-related direct medical costs. Methods: We used a retrospective chart review to determine 18-month RVO-related resource utilization and calculate 12-month health care costs. Country-specific unit costs (€) were assigned to each resource from the perspective of the health care payer. Costs for France and Germany were based on 2005, and for Italy on 2007 values. Results: Data from a total of 109 BRVO and 119 patients with CRVO were used in the analysis. Laser therapy was the most commonly used intervention in Germany, for both CRVO and patients with BRVO (95%-98% of treatments), while patients in France with either condition had triamcinolone injections most often (63%-67% of treatments). Injections were also administered frequently in Italy and were the most common treatment for CRVO (50%), whereas patients with BRVO used laser therapy most often (41%). Inpatient treatment was most common in Germany (42% of CRVO and 34% of patients with BRVO), and did not occur at all in Italy except for day admissions. Total costs were higher for patients with CRVO in all countries. Most costs in Italy and France were attributable to outpatient treatment. In Germany, hospitalization made up the largest proportion of costs (80%), although more patients used outpatient services. Conclusions: Approaches to treating BRVO and CRVO vary across European countries. Development of agreed-upon guidelines would support consistency in patient care and reimbursement policy.

Overview

Integrity signals

Registry

Crossref · 10.5301/ejo.5000180

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 3

  1. Chen J.C., 1995, Can J Ophthalmol, 30, 21
  2. Journal Officiel de la République Française (2006). Available at: http://textes.droit.org/JORF/2006/03/23/0070/. Accessed June 2009.
  3. Gewaily D., 2009, Cochrane Database Syst Rev, 1, CD007324

Cited by

See all 8

Metadata

Authors
Augustin, A. J., Sahel, J.-A., Cerulli, L., Texier-Richard, B., Buchholz, P. M., & Kobelt, G.
Affiliations
  • Städtisches Klinikum Karlsruhe (DE)
  • INSERM, U968, Paris - France
  • University of Rome Tor Vergata (IT)
  • European Health Economics SAS, Spéracèdes - France
  • Allergan (Germany) (DE)
  • European Health Economics SAS, Mulhouse - France
Corresponding author
Augustin, Albert J.
Venue
European Journal of Ophthalmology
Published
2012-09
Volume
22
Issue
5
Pages
776-784
ISSN
  • 1120-6721 (ISSN-L)
  • 1724-6016
OpenAlex
W2084220761
Cited by
7
References
19
Citations by year
2025: 1 · 2021: 1 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 1
FWCI
0.30
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • European Journal of Ophthalmology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
  • Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
Keywords
retinal vein occlusion, central retinal vein occlusion, branch retinal vein occlusion, treatment patterns, health care costs, resource utilization (health care), laser therapy, triamcinolone injection, hospitalization, outpatient care, cross-national comparison, France, Germany, Italy
MeSH terms
Aged, Female, France, Germany, Glucocorticoids, Health Resources, Health Services Research, Humans, Inpatients, Italy, Macular Edema, Male, Middle Aged, Outpatients, Practice Patterns, Physicians', Retinal Vein Occlusion, Retrospective Studies, Triamcinolone Acetonide, Visual Acuity, Health Care Costs, Laser Coagulation, Intravitreal Injections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.